XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.640
-0.070 (-2.58%)
At close: Jan 28, 2026, 4:00 PM EST
2.640
0.00 (0.00%)
After-hours: Jan 28, 2026, 4:00 PM EST
XBiotech Market Cap
XBiotech has a market cap or net worth of $80.03 million as of January 28, 2026. Its market cap has decreased by -32.35% in one year.
Market Cap
80.03M
Enterprise Value
-67.34M
1-Year Change
-32.35%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $80.03M, a decrease of -89.15%. That is a compound annual growth rate of -18.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 82.60M | 13.31% |
| Dec 31, 2025 | 72.90M | -39.45% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 88.46M |
| Adicet Bio | 86.31M |
| ALX Oncology Holdings | 81.33M |
| OKYO Pharma | 80.11M |
| Pelthos Therapeutics | 79.90M |
| PolyPid | 79.85M |
| Gain Therapeutics | 79.23M |
| Equillium | 79.16M |